Status
Conditions
Treatments
About
The study will investigate the role of 1,3-butadiene metabolic activation and deactivation in lung cancer risk among various ethnic/racial groups. This project will require urine samples from smokers and nonsmokers from the three ethnic/racial groups recruited by the Clinical and Biomarker Core for the analysis of 1,3-butadiene DNA adducts. Data on nicotine intake (urinary TNE) in these subjects as well as in 400 lung cancer cases and 400 controls from Project 1 will be also required for this project.
Sex
Ages
Volunteers
Inclusion criteria
One of the three targeted ethnic groups:
Smoke 5 cigarettes per day over the past three months;
>21 years of age;
Consumes 14 or fewer drinks of alcohol per week;
Generally stable and good health (determined by review of medical history);
Able to provide written voluntary consent before performance of any study related procedure.
Exclusion criteria
0 participants in 3 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal